The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective validation cohort study of baseline plasma cell-free DNA (cfDNA) as a prognostic biomarker in newly diagnosed glioblastoma (GBM).
 
Stephen Joseph Bagley
Consulting or Advisory Role - Bayer; Novocure
Research Funding - Guardant Health; Incyte; Lilly; Novocure; Tesaro
Travel, Accommodations, Expenses - Northwest Biotherapeutics
 
Seyed Ali Nabavizadeh
No Relationships to Disclose
 
Jacob Till
No Relationships to Disclose
 
Aseel Abdalla
No Relationships to Disclose
 
Hareena Sanga
No Relationships to Disclose
 
Jazmine Mays
No Relationships to Disclose
 
Timothy Prior
No Relationships to Disclose
 
Andrew Jurgielewicz
No Relationships to Disclose
 
Samantha Guiry
No Relationships to Disclose
 
Karapet Davtyan
No Relationships to Disclose
 
Stephanie S. Yee
No Relationships to Disclose
 
Zev A Binder
No Relationships to Disclose
 
Donald M. O'Rourke
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - ErbB tumors and radiation therapy (Inst); Multiple patent applications on CART cells in solid tumors (Inst)
 
Steven Brem
No Relationships to Disclose
 
Arati Suvas Desai
No Relationships to Disclose
 
Erica L. Carpenter
Honoraria - AstraZeneca
Research Funding - Becton Dickinson (Inst); Janssen (Inst); Merck (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Invention disclosure entitled, "Methods and Compositions for Identifying, Diagnosing and Treating Neuroblastoma"; Invention disclosure entitled, "Methods and Compositions for Identifying, Diagnosing and Treating Neuroblastoma"; Invention disclosure entitled, "Methods and Compositions for Treating Neuroblastoma"
Travel, Accommodations, Expenses - AstraZeneca; Foundation Medicine